Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers

BACKGROUND The ABCD stratification [(combination of serum pepsinogen (PG) levels and titers of antibody (immunoglobulin G, IgG) against Helicobacter pylori (H. pylori)] is effective for the classification of individuals at risk of developing gastric cancer (GC). The Kita–Kyushu lung cancer antigen-1 (KK-LC-1) is a Cancer/Testis antigen frequently expressed in GC. AIM To evaluate the effectiveness of KK-LC-1 and ABCD stratification in the diagnosis of GC. METHODS We analyzed the gene expression of KK-LC-1 in surgical specimens obtained from GC tumors. The levels of serum PG I/PG II and IgG against H. pylori were measured. According to their serological status, the patients were classified into the four groups of the ABCD stratification. RESULTS Of the 77 examined patients, 63 (81.8%) expressed KK-LC-1. The IgG titers of H. pylori and PG II were significantly higher in patients expressing KK-LC-1 than those measured in patients not expressing KK-LC-1 (P = 0.0289 and P = 0.0041, respectively). The expression of KK-LC-1 in group C [PG method (+)/H. pylori infection (+)] was as high as 93.9% high. KK-LC-1 was also detected in group A [-/-]. CONCLUSION The KK-LC-1 expression in GC was associated with H. pylori infection and atrophic status, so that, KK-LC-1 may be a useful marker for the diagnosis of GC.

[1]  Y. Liu,et al.  Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening , 2018, Chinese medical journal.

[2]  K. Yasumoto,et al.  Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumour , 2018, Scientific Reports.

[3]  Masahiko Watanabe,et al.  Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen , 2017, World journal of gastroenterology.

[4]  H. Nonoguchi,et al.  Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and Helicobacter pylori Infection in Gastric Cancer. , 2017, In vivo.

[5]  B. Howie,et al.  Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer , 2017, Science.

[6]  Ö. Türeci,et al.  CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer , 2015, Oncotarget.

[7]  Masahiko Watanabe,et al.  Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer. , 2015, Anticancer research.

[8]  M. Mori,et al.  Analysis of ABC (D) stratification for screening patients with gastric cancer. , 2011, World journal of gastroenterology.

[9]  Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.

[10]  K. Haruma,et al.  Assessment of Degree of Health of the Stomach by Concomitant Measurement of Serum Pepsinogen and Serum Helicobacter Pylori Antibodies , 2010, The International journal of biological markers.

[11]  Kenji Takahashi,et al.  Serum pepsinogens as a screening test of extensive chronic gastritis , 1987, Gastroenterologia Japonica.

[12]  K. Sugio,et al.  Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma. , 2006, Cancer research.

[13]  N. Yoshimura,et al.  Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer , 2004, International journal of cancer.

[14]  胃癌研究会 Japanese classification of gastric carcinoma , 1995 .

[15]  M. Matsushima,et al.  The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. , 1995, Advances in experimental medicine and biology.

[16]  K. Miki,et al.  Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. , 1982, Clinica chimica acta; international journal of clinical chemistry.